Skip to main content
Equibles

Walleye Trading LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1388391 NEW YORK, NY
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$15,974,894
+$928,870 QoQ
Shares Held
471,514
-5.6% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#119
of 675 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2026
CallValue
$84,967,652
CallShares
2,507,900
PutValue
$48,309,492
PutShares
1,425,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Walleye Trading LLC holds $100,878,368 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (15.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,002,966 $72,073,136
2 TEVA
Teva Pharmaceutical Industries Ltd
This page 		471,514 $15,974,894
3 HIMS
Hims & Hers Health, Inc.
 287,756 $9,976,500
4 ELAN
Elanco Animal Health Inc
 42,073 $1,035,416
5 BHC
Bausch Health Companies Inc.
 135,199 $666,531
6 VTRS
Viatris Inc
 36,152 $574,093
7 TLRY
Tilray Brands, Inc.
 63,168 $283,624
8 NBIX
Neurocrine Biosciences Inc
 1,200 $202,248

All Filings in TEVA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $84,967,652 2,507,900
2026-06-30 $15,974,894 471,514
2026-06-30 $48,309,492 1,425,900
2026-03-31 $15,046,024 499,536
2026-03-31 $77,324,064 2,567,200
2026-03-31 $63,523,080 2,109,000
2025-12-31 $16,633,744 532,962
2025-12-31 $28,176,388 902,800
2025-12-31 $56,468,253 1,809,300
2025-09-30 $29,427,360 1,456,800
2025-09-30 $45,720,680 2,263,400
2025-09-30 $22,025,938 1,090,393
2025-06-30 $16,697,384 996,264
2025-06-30 $34,614,428 2,065,300
2025-06-30 $31,983,108 1,908,300
2025-03-31 $16,925,444 1,101,200
2025-03-31 $8,279,819 538,700
2025-03-31 $13,140,105 854,919
2024-12-31 $22,914,988 1,039,700
2024-12-31 $22,855,480 1,037,000
2024-09-30 $13,439,316 745,800
2024-09-30 $6,795,378 377,102
2024-09-30 $6,840,392 379,600
2024-06-30 $28,928,250 1,780,200
2024-06-30 $10,467,193 644,135
2024-06-30 $5,772,000 355,200
2024-03-31 $4,533,543 321,300
2024-03-31 $4,899,358 347,226
2024-03-31 $6,341,034 449,400
2023-12-31 $5,187,260 496,864
2023-12-31 $6,016,572 576,300
2023-12-31 $1,398,960 134,000
2023-09-30 $8,856,660 868,300
2023-09-30 $3,166,080 310,400
2023-09-30 $5,827,198 571,294
2023-06-30 $3,423,138 454,600
2023-06-30 $1,527,837 202,900
2023-03-31 $3,193,080 360,800
2023-03-31 $3,236,445 365,700
2022-12-31 $1,305,072 143,100
2022-12-31 $1,571,376 172,300
2022-09-30 $2,652,609 328,700
2022-09-30 $2,382,264 295,200
2022-06-30 $3,244,880 431,500
2022-06-30 $3,347,904 445,200
2022-03-31 $6,167,352 656,800
2022-03-31 $5,940,114 632,600
2021-12-31 $2,294,064 286,400
2021-12-31 $1,649,259 205,900
2021-09-30 $2,045,400 210,000